Skip to content

Validation of a Model for Predicting Anastomotic Leakage

Validation of a Machine Learning Model for Predicting Anastomotic Leakage of Esophagogastrostomy and Esophagojejunostomy: A Multicenter Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05646290
Enrollment
512
Registered
2022-12-12
Start date
2022-01-06
Completion date
2024-05-06
Last updated
2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Keywords

machine learning, anastomotic leakage, total and proximal gastrectomy

Brief summary

This study will validate a machine learning model for predicting anastomotic leakage of esophagogastrostomy and esophagojejunostomy.

Detailed description

Anastomotic leakage is a fatal complication after total and proximal gastrectomy in gastric cancer patients. Identifying patients with high-risk of AL is important for guiding the surgeons' decision making, such as a more rigorous anastomotic operation, placing a jejunal feeding tube and dual-lumen flushable drainage catheter. We have developed a high-performance machine learning model based on 1660 gastric cancer patients, which showed good discrimination of anastomotic leakage. Hence, this multi-center prospective study will validiate the usability of the model for predicting anastomotic leakage in gastric cancer patients who receive total and proximal gastrectomy.

Interventions

None listed

Sponsors

Jichao Qin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Inclusion Criteria: 1. Aged older than 18 years and younger than 85 years. 2. Primary gastric adenocarcinoma confirmed by preoperative pathology. 3. Expected curative resection via total or proximal gastrectomy. 4. American Society of Anesthesiologists (ASA) class I, II, or III. 5. Written informed consent.

Exclusion criteria

1. Pregnant or breastfeeding women. 2. Severe mental disorder or language communication disorder. 3. Other surgical procedures of gastrectomy is performed. 4. Interrupted of surgery for more than 30 minutes due to any cause. 5. Malignant tumors with other organs

Design outcomes

Primary

MeasureTime frame
Incidence of anastomotic leakageWithin 30 days after operation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026